Intervention Review

You have free access to this content

Pharmacological treatment of depression in patients with a primary brain tumour

  1. Alasdair Rooney*,
  2. Robin Grant

Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 31 MAY 2013

Assessed as up-to-date: 29 APR 2013

DOI: 10.1002/14651858.CD006932.pub3


How to Cite

Rooney A, Grant R. Pharmacological treatment of depression in patients with a primary brain tumour. Cochrane Database of Systematic Reviews 2013, Issue 5. Art. No.: CD006932. DOI: 10.1002/14651858.CD006932.pub3.

Author Information

  1. Western General Hospital, Edinburgh Centre for Neuro-Oncology (ECNO), Edinburgh, Scotland, UK

*Alasdair Rooney, Edinburgh Centre for Neuro-Oncology (ECNO), Western General Hospital, Crewe Road South, Edinburgh, Scotland, EH4 2XU, UK. ally.rooney@ed.ac.uk. ally.rooney@ed.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 31 MAY 2013

SEARCH

 
Characteristics of excluded studies [ordered by study ID]

StudyReason for exclusion

Caudill 2011Treatment of depression was based on routine clinical care (not systematically controlled)

Koval'chuk 2007Depression was not a necessary inclusion criterion

Litofsky 2004Treatment of depression was not systematically controlled
Depression was not a necessary inclusion criterion

Meyers 1998Patients with severe depression were excluded and the study was not limited to those with milder depression

Morrow 2003Depression was not a necessary study inclusion criterion
Data for brain tumour patients were not presented separately

Moss 2006Depression was not a necessary study inclusion criterion
Data for brain tumour patients were not presented separately

Oyewumi 1981Single case study

Rabey 19853 case studies; brain tumour not diagnosed at time of antidepressant prescription

Shaw 2006Depression was not a necessary inclusion criterion

Wellisch 2006Could not confirm whether depression was a necessary inclusion criterion